The drugbank database (https://www.drugbank.ca) also reports CAD candidate gene LRP1 and its first neighbor CALR as targets for the fibrinolytic agent tenecteplase (recombinant tissue plasminogen activator tPA). This evidence concerns the gene PLAT and coronary artery disorder.